Newsfeeds - Spark Newswire

4 minute read

Events
News

Jazz Pharmaceuticals Presented Interim Phase 2/3 Results of Rylaze in Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma at ASH 2021; Said Rylaze Maintains Clinically Meaningful Level of Asparaginase Activity Throughout the Entire Duration of Treat…

Today, 4:01 PM

Jazz Pharmaceuticals plc (NASDAQ: JAZZ) today announced initial positive results from a Phase 2/3 trial of intramuscular (IM) administration of Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn) in adult and pediatric patients with acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL) who have d

JAZZ

2 minute read

News

Redx to Receive Milestone Payment of $10m from Jazz

By Charles Gross

Today, 4:01 PM

Redx (AIM: REDX), the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, highly targeted therapeutics for the treatment of cancer and fibrotic disease, today announces that a milestone payment from Jazz Pharmaceuticals (NASDAQ: JAZZ) has been triggered as a result of entering the

JAZZ

2 minute read

EXCLUSIVE: Cannabis-Based Drug Approved For Cancer Treatment In Peru

By Javier Hasse

Today, 4:01 PM

Cannabis-based drug Sativyl has been approved as a treatment for cancer-related pain in Peru.

CLVR

9 minute read

The Week In Cannabis: Earnings Season, A GOP Legalization Bill, Seth Rogen & Sarah Silverman’s Campaign

By Javier Hasse

Today, 4:01 PM

Below is a recap of the main news related to the cannabis industry and markets for the week of November 8, 2021. Contents

AAWH

3 minute read

Jazz Pharmaceuticals Reports Q3 Financial Results, Raises Full-Year Earnings Guidance

By Nicolas Jose Rodriguez

Today, 4:01 PM

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a global biopharmaceutical company, announced its financial results Tuesday afternoon for the third quarter of 2021 and updated financial guidance for 2021.

GWPH

6 minute read

The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data

By Shanthi Rexaline

Today, 4:01 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

ACHV

21 minute read

Earnings Scheduled For November 9, 2021

By Benzinga Insights

Today, 4:01 PM

Companies Reporting Before The Bell • Imara (NASDAQ:IMRA) is projected to report earnings for its third quarter. • KT (NYSE:KT) is projected to report earnings for its third quarter.

AAIC

6 minute read

Jazz Pharmaceuticals To Present Data Showcasing Clinical Advances Across Hematology/Oncology At ASH 2021 Annual Meeting

By Benzinga Newsdesk

Today, 4:01 PM

Jazz Pharmaceuticals plc (NASDAQ:JAZZ) today announced that 16 new data abstracts from across its hematology/oncology development program will be presented at the 63rd American Society of Hematology (ASH)

JAZZ

4 minute read

The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US

By Shanthi Rexaline

Today, 4:01 PM

Here's a roundup of top developments in the biotech space over the last 24 hours:

AADI

1 minute read

Lexaria Announces DehydraTECH-CBD Versus Prescription CBD Program In Treating Seizures

By Vandana Singh

Today, 4:01 PM

Lexaria Bioscience Corp (NASDAQ:LEXX) has commenced a new study to compare the effectiveness of Epidiolex to DehydraTECH-cannabidiol (CBD) for reducing seizure…

JAZZ